Abbott Laboratories

Yahoo Finance • 4 hours ago

Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects?

Abbott Laboratories (NYSE:ABT) has had a rough three months with its share price down 13%. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Specific... Full story

Yahoo Finance • 2 days ago

Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio

This article first appeared on GuruFocus. Exploring the Strategic Moves of a Seasoned Value Investor Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insights into his investmen... Full story

Yahoo Finance • 2 days ago

Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Exact Sciences at around US$103 a share still offers value, you are not alone. This article is... Full story

Yahoo Finance • 6 days ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Reliance Global Group Inc. 126,947,180 0.2233 0.187 0.1966 +0.0346 MINT... Full story

Yahoo Finance • 7 days ago

Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating

Abbott Laboratories (NYSE:ABT) is one of the best 52-week low blue-chip stocks to buy right now. Reuters reported on February 4 that Abbott Laboratories (NYSE:ABT) has logged 860 serious injuries tied to the recall of certain FreeStyle Lib... Full story

Yahoo Finance • 8 days ago

Insider trades: Merck, Intel, Micron among notable names

[Insider trading is shown on the business photo using the text] Andrii Dodonov A weekly overview of insider trading, highlighting significant purchases and sales by investors, directors, and executives. The transactions occurred between F... Full story

Yahoo Finance • 8 days ago

Insider Stock Buying Reaches US$3.10m On Abbott Laboratories

Over the last year, a good number of insiders have significantly increased their holdings in Abbott Laboratories (NYSE:ABT). This is encouraging because it indicates that insiders are more optimistic about the company's prospects. While i... Full story

Yahoo Finance • 9 days ago

Diamond Hill Capital's Strategic Moves: HCA Healthcare Inc. Reduced by 1.25%

This article first appeared on GuruFocus. Insight into Diamond Hill Capital (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Warning! GuruFocus has detected 2 Warning Sign with AIG. Is AIG fairly valued? Test your thesis with our fre... Full story

Yahoo Finance • 9 days ago

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Electrophysiology, reinforce the Volt™ Pulsed Field Ablation (PFA) System's industry-leading success rate for... Full story

Yahoo Finance • 10 days ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors Inaugural launch of Omnipod Discover... Full story

Yahoo Finance • 11 days ago

Medtronic Expands Heart And Diabetes Tools As Valuation Nears Analyst Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Medtronic (NYSE:MDT) announced an agreement to acquire CathWorks, aiming to add AI-powered coronar... Full story

Yahoo Finance • 11 days ago

Abbott Laboratories Recall of FreeStyle Libre 3 Glucose Sensors Updated, FDA Says

Abbott Laboratories' (ABT) recall notice for certain FreeStyle Libre 3 and Libre 3 Plus glucose sens PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 12 days ago

Abbott Faces FDA Scrutiny On FreeStyle Libre And Broader Quality Story

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning letter focused on the accuracy and testing... Full story

Yahoo Finance • 12 days ago

Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure

Abbott Laboratories (NYSE:ABT) is included among the Dividend Growth Stocks: 25 Aristocrats.Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure Courtesy of Abbott Labs A Reuters report said Abbott Laboratori... Full story

Yahoo Finance • 12 days ago

Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

nPulse Cardiac Catheter for AF ablation to be highlighted in late-breaking clinical science session and in a live case transmission HAYWARD, Calif., February 03, 2026--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company lev... Full story

Yahoo Finance • 13 days ago

Abbott Laboratories (ABT): A Bull Case Theory

We came across a bullish thesis on Abbott Laboratories on R. Dennis’s SubstackR. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories's share was trading at $106.09 as of January 29... Full story

Yahoo Finance • 13 days ago

Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to r... Full story

Yahoo Finance • 13 days ago

The Best Dividend King to Buy With $150

Shares of Abbott Laboratories(NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away from Abbott given some recent challenges.... Full story

Yahoo Finance • 13 days ago

Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances

GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and... Full story

Yahoo Finance • 2 months ago

Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment

Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026.Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment Courtesy of Abbott Labs On December 22, Abbott Laboratories (NYSE:ABT... Full story